Galecto to Participate at Upcoming Investor Conferences
A live webcast of the presentation at SVB Leerink will be available on the "News & Events" section of Galectos Investor website at https://ir.galecto.com/news-and-events/events .
- A live webcast of the presentation at SVB Leerink will be available on the "News & Events" section of Galectos Investor website at https://ir.galecto.com/news-and-events/events .
- A replay of the presentation will be available on this same website following the event.
- Galecto is a clinical stage company incorporated in the U.S. that is developing small molecule-based inhibitors of galectin-3 (and the galectin family generally) and LOXL2.
- Galecto intends to use its website as a means of disclosing material non-public information.